Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
By J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, Klaus Cychutek, C. Koch-Brandt, R. Alyautdin. Journal of drug targeting (Print), 2002
788 citations recorded by the source corpus.
Subfields: Pediatrics, Perinatology and Child Health, Pharmaceutical Science, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/b47c9014b10535a20742d88df16da30c80f4d1a9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pediatrics, Perinatology and Child Health
In Pharmaceutical Science
Citations in the corpus
- Translocation of Inhaled Ultrafine Particles to the Brain (2004, background): “Only after coating intravenously injected nanoparticles with polysorbate or apolipoprotein did they seem to mimic lipoprotein particles that could be taken up by brain capillary endothelial cells via receptor-mediated phagocytosis (Kreuter et al., 2002).”
- Deposition and biokinetics of inhaled nanoparticles (2010, background): “Apolipoprotein-E coating of nanoparticles for LDL receptor mediated endocytosis in brain capillaries has been discussed [74-76].”
- Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. (2006, background): “Thus, following inhalation exposure, NP have been reported to travel via the nasal nerves to the brain (Kreuter et al., 2002; Oberdorster et al., 2004), as has been described for poliovirus (Bodian and Howe, 1941), and to gain access to the blood and other organs (Kreyling et al.”
- Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle (2013, background): “Receptor mediated endocytosis was speculated to be the means of uptake in this case [55,56].”
- Treating metastatic cancer with nanotechnology (2011, neutral): “These ApoE-decorated particles can mediate BBB deliver”
- Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. (2010, background): “A possible mechanism is that polysorbate 80 (tween-80) coated polybutyl-cyanoacrylate nanoparticles adsorb apolipoprotein E and B from the bloodstream after IV injection (Kreuter et al., 2002) and therefore use LRP for transcytosis across the BBB.”